▶ 調査レポート

世界のカンナビノイド生合成市場規模・現状・予測(2021年-2027年)

• 英文タイトル:Global Biosynthesis of Cannabinoids Market Size, Status and Forecast 2021-2027

QYResearchが調査・発行した産業分析レポートです。世界のカンナビノイド生合成市場規模・現状・予測(2021年-2027年) / Global Biosynthesis of Cannabinoids Market Size, Status and Forecast 2021-2027 / QFJ1-5413資料のイメージです。• レポートコード:QFJ1-5413
• 出版社/出版日:QYResearch / 2021年6月
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、105ページ
• 納品方法:Eメール(納期:3日)
• 産業分類:新技術
• 販売価格(消費税別)
  Single User¥577,200 (USD3,900)▷ お問い合わせ
  Multi User¥865,800 (USD5,850)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
QYResearch社発行の本調査レポートでは、カンナビノイド生合成の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(THC、CBD、その他)、用途別市場規模(食品産業、医療産業、その他)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・カンナビノイド生合成の市場動向
・企業の競争状況、市場シェア
・カンナビノイド生合成の種類別市場規模と予測2016-2027(THC、CBD、その他)
・カンナビノイド生合成の用途別市場規模と予測2016-2027(食品産業、医療産業、その他)
・カンナビノイド生合成の北米市場規模2016-2027(アメリカ、カナダ)
・カンナビノイド生合成の欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・カンナビノイド生合成のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・カンナビノイド生合成の中南米市場規模2016-2027(メキシコ、ブラジル)
・カンナビノイド生合成の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Anandia Laboratories、Gingko Bioworks、Hyasynth Bio、InMed Pharmaceuticals、Librede、Renew Biopharma、Cronos Group、Organigram、Teewinot Life Sciences、ICC International Cannabis Corp.、Biotii Technologies Corp.、Bristol-Myers Squibb、Biogen Inc.、GW Pharmaceuticals)
・結論

Cannabinoids are found in the cannabis plant, they can be produced in biosynthesis way. While biosynthesis has not yet proven itself as a scalable technology, it has the potential to radically alter the way cannabinoids are manufactured in the near future.These compounds are the exact same as what cannabis expresses.

In 2021, the global Biosynthesis of Cannabinoids market size will be US$ XX million and it is expected to reach US$ XX million by the end of 2027, with a CAGR of XX% during 2021-2027.
This report focuses on the global Biosynthesis of Cannabinoids status, future forecast, growth opportunity, key market, and key players. The study objectives are to present the Biosynthesis of Cannabinoids development in North America, Europe, Japan, China, Southeast Asia, India, etc.

Global Biosynthesis of Cannabinoids Scope and Market Size
Biosynthesis of Cannabinoids market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Biosynthesis of Cannabinoids market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
THC
CBD
Others

Segment by Application
Food Industry
Medical Industry
Others

By Region
North America
Europe
Japan
China
Southeast Asia
India

By Company
Anandia Laboratories
Gingko Bioworks
Hyasynth Bio
InMed Pharmaceuticals
Librede
Renew Biopharma
Cronos Group
Organigram
Teewinot Life Sciences
ICC International Cannabis Corp.
Biotii Technologies Corp.
Bristol-Myers Squibb
Biogen Inc.
GW Pharmaceuticals

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biosynthesis of Cannabinoids Market Size Growth Rate by Type (2021-2027)
1.2.2 THC
1.2.3 CBD
1.2.4 Others
1.3 Market by Application
1.3.1 Global Biosynthesis of Cannabinoids Market Share by Application (2021-2027)
1.3.2 Food Industry
1.3.3 Medical Industry
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
2.1 Global Biosynthesis of Cannabinoids Market Size
2.2 Biosynthesis of Cannabinoids Market Size by Regions
2.2.1 Biosynthesis of Cannabinoids Growth Rate by Regions (2021-2027)
2.2.2 Biosynthesis of Cannabinoids Market Share by Regions (2021-2027)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Use Cases

3 Key Players
3.1 Biosynthesis of Cannabinoids Revenue by Players (2020-2021)
3.2 Biosynthesis of Cannabinoids Key Players Headquaters and Area Served
3.3 Key Players Biosynthesis of Cannabinoids Product/Solution/Service
3.4 Date of Enter into Biosynthesis of Cannabinoids Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown by Type and by Application
4.1 Global Biosynthesis of Cannabinoids Market Size by Type (2021-2027)
4.2 Global Biosynthesis of Cannabinoids Market Size by Application (2021-2027)

5 North America
5.1 North America Biosynthesis of Cannabinoids Market Forecast (2021-2027)
5.2 Biosynthesis of Cannabinoids Key Players in North America
5.3 North America Biosynthesis of Cannabinoids Market Size by Type
5.4 North America Biosynthesis of Cannabinoids Market Size by Application
6.4.4 Canada

6 Europe
6.1 Europe Biosynthesis of Cannabinoids Market Forecast (2021-2027)
6.2 Biosynthesis of Cannabinoids Key Players in Europe
6.3 Europe Biosynthesis of Cannabinoids Market Size by Type
6.4 Europe Biosynthesis of Cannabinoids Market Size by Application

7 Japan
7.1 Japan Biosynthesis of Cannabinoids Market Forecast (2021-2027)
7.2 Biosynthesis of Cannabinoids Key Players in Europe
7.3 Japan Biosynthesis of Cannabinoids Market Size by Type
7.4 Japan Biosynthesis of Cannabinoids Market Size by Application

8 Rest of World
8.1 China
8.1.1 China Biosynthesis of Cannabinoids Market Analysis
8.1.2 Key Players in China
8.2 Southeast Asia
8.2.1 Southeast Asia Biosynthesis of Cannabinoids Market Analysis
8.2.2 Key Players in Southeast Asia
8.3 India
8.3.1 India Biosynthesis of Cannabinoids Market Analysis
8.3.2 Key Players in India

9 International Player Profiles
9.1 Anandia Laboratories
9.1.1 Anandia Laboratories Company Details
9.1.2 Anandia Laboratories Description and Business Overview
9.1.3 Anandia Laboratories Biosynthesis of Cannabinoids Introduction
9.1.4 Anandia Laboratories Revenue in Biosynthesis of Cannabinoids Business (2020-2021)
9.1.5 Anandia Laboratories Recent Development
9.2 Gingko Bioworks
9.2.1 Gingko Bioworks Company Details
9.2.2 Gingko Bioworks Description and Business Overview
9.2.3 Gingko Bioworks Biosynthesis of Cannabinoids Introduction
9.2.4 Gingko Bioworks Revenue in Biosynthesis of Cannabinoids Business (2020-2021)
9.2.5 Gingko Bioworks Recent Development
9.3 Hyasynth Bio
9.3.1 Hyasynth Bio Company Details
9.3.2 Hyasynth Bio Description and Business Overview
9.3.3 Hyasynth Bio Biosynthesis of Cannabinoids Introduction
9.3.4 Hyasynth Bio Revenue in Biosynthesis of Cannabinoids Business (2020-2021)
9.3.5 Hyasynth Bio Recent Development
9.4 InMed Pharmaceuticals
9.4.1 InMed Pharmaceuticals Company Details
9.4.2 InMed Pharmaceuticals Description and Business Overview
9.4.3 InMed Pharmaceuticals Biosynthesis of Cannabinoids Introduction
9.4.4 InMed Pharmaceuticals Revenue in Biosynthesis of Cannabinoids Business (2020-2021)
9.4.5 InMed Pharmaceuticals Recent Development
9.5 Librede
9.5.1 Librede Company Details
9.5.2 Librede Description and Business Overview
9.5.3 Librede Biosynthesis of Cannabinoids Introduction
9.5.4 Librede Revenue in Biosynthesis of Cannabinoids Business (2020-2021)
9.5.5 Librede Recent Development
9.6 Renew Biopharma
9.6.1 Renew Biopharma Company Details
9.6.2 Renew Biopharma Description and Business Overview
9.6.3 Renew Biopharma Biosynthesis of Cannabinoids Introduction
9.6.4 Renew Biopharma Revenue in Biosynthesis of Cannabinoids Business (2020-2021)
9.6.5 Renew Biopharma Recent Development
9.7 Cronos Group
9.7.1 Cronos Group Company Details
9.7.2 Cronos Group Description and Business Overview
9.7.3 Cronos Group Biosynthesis of Cannabinoids Introduction
9.7.4 Cronos Group Revenue in Biosynthesis of Cannabinoids Business (2020-2021)
9.7.5 Cronos Group Recent Development
9.8 Organigram
9.8.1 Organigram Company Details
9.8.2 Organigram Description and Business Overview
9.8.3 Organigram Biosynthesis of Cannabinoids Introduction
9.8.4 Organigram Revenue in Biosynthesis of Cannabinoids Business (2020-2021)
9.8.5 Organigram Recent Development
9.9 Teewinot Life Sciences
9.9.1 Teewinot Life Sciences Company Details
9.9.2 Teewinot Life Sciences Description and Business Overview
9.9.3 Teewinot Life Sciences Biosynthesis of Cannabinoids Introduction
9.9.4 Teewinot Life Sciences Revenue in Biosynthesis of Cannabinoids Business (2020-2021)
9.9.5 Teewinot Life Sciences Recent Development
9.10 ICC International Cannabis Corp.
9.10.1 ICC International Cannabis Corp. Company Details
9.10.2 ICC International Cannabis Corp. Description and Business Overview
9.10.3 ICC International Cannabis Corp. Biosynthesis of Cannabinoids Introduction
9.10.4 ICC International Cannabis Corp. Revenue in Biosynthesis of Cannabinoids Business (2020-2021)
9.10.5 ICC International Cannabis Corp. Recent Development
9.11 Biotii Technologies Corp.
9.11.1 Biotii Technologies Corp. Company Details
9.11.2 Biotii Technologies Corp. Description and Business Overview
9.11.3 Biotii Technologies Corp. Biosynthesis of Cannabinoids Introduction
9.11.4 Biotii Technologies Corp. Revenue in Biosynthesis of Cannabinoids Business (2020-2021)
9.11.5 Biotii Technologies Corp. Recent Development
9.12 Bristol-Myers Squibb
9.12.1 Bristol-Myers Squibb Company Details
9.12.2 Bristol-Myers Squibb Description and Business Overview
9.12.3 Bristol-Myers Squibb Biosynthesis of Cannabinoids Introduction
9.12.4 Bristol-Myers Squibb Revenue in Biosynthesis of Cannabinoids Business (2020-2021)
9.12.5 Bristol-Myers Squibb Recent Development
9.13 Biogen Inc.
9.13.1 Biogen Inc. Company Details
9.13.2 Biogen Inc. Description and Business Overview
9.13.3 Biogen Inc. Biosynthesis of Cannabinoids Introduction
9.13.4 Biogen Inc. Revenue in Biosynthesis of Cannabinoids Business (2020-2021)
9.13.5 Biogen Inc. Recent Development
9.14 GW Pharmaceuticals
9.14.1 GW Pharmaceuticals Company Details
9.14.2 GW Pharmaceuticals Description and Business Overview
9.14.3 GW Pharmaceuticals Biosynthesis of Cannabinoids Introduction
9.14.4 GW Pharmaceuticals Revenue in Biosynthesis of Cannabinoids Business (2020-2021)
9.14.5 GW Pharmaceuticals Recent Development

10 Market Dynamics
10.1 Industry Trends
10.2 Market Drives
10.3 Market Challenges
10.4 Market Restraints

11 Key Findings in This Report
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.2 Data Source
12.2 Disclaimer
12.3 Author Details

List of Tables
Table 1. Global Biosynthesis of Cannabinoids Market Size Growth Rate by Type (2021-2027) (US$ Million)
Table 2. Key Players of THC
Table 3. Key Players of CBD
Table 4. Key Players of Others
Table 5. Global Biosynthesis of Cannabinoids Market Size Growth by Application (2021-2027) (US$ Million)
Table 6. Global Biosynthesis of Cannabinoids Market Size by Regions (2021-2027) (US$ Million)
Table 7. Global Biosynthesis of Cannabinoids Market Share by Regions (2021-2027)
Table 8. Market Top Trends
Table 9. Market Use Cases
Table 10. Global Biosynthesis of Cannabinoids Revenue by Players (2020-2021) (US$ Million)
Table 11. Global Biosynthesis of Cannabinoids Market Share by Players (2020-2021)
Table 12. Key Players Headquarters and Area Served
Table 13. Key Players Biosynthesis of Cannabinoids Product Solution and Service
Table 14. Date of Enter into Biosynthesis of Cannabinoids Market
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Biosynthesis of Cannabinoids Market Size by Type (2021-2027) (US$ Million)
Table 17. Global Biosynthesis of Cannabinoids Market Size Share by Type (2021-2027)
Table 18. Global Biosynthesis of Cannabinoids Market Size by Application (2021-2027) (US$ Million)
Table 19. Global Biosynthesis of Cannabinoids Market Size Share by Application (2021-2027)
Table 20. North America Key Players Biosynthesis of Cannabinoids Revenue (2020-2021) (US$ Million)
Table 21. North America Key Players Biosynthesis of Cannabinoids Market Share (2020-2021)
Table 22. North America Biosynthesis of Cannabinoids Market Size by Type (2021-2027) (US$ Million)
Table 23. North America Biosynthesis of Cannabinoids Market Share by Type (2021-2027)
Table 24. North America Biosynthesis of Cannabinoids Market Size by Application (2021-2027) (US$ Million)
Table 25. North America Biosynthesis of Cannabinoids Market Share by Application (2021-2027)
Table 26. Europe Key Players Biosynthesis of Cannabinoids Revenue (2020-2021) (US$ Million)
Table 27. Europe Key Players Biosynthesis of Cannabinoids Market Share (2020-2021)
Table 28. Europe Biosynthesis of Cannabinoids Market Size by Type (2021-2027) (US$ Million)
Table 29. Europe Biosynthesis of Cannabinoids Market Share by Type (2021-2027)
Table 30. Europe Biosynthesis of Cannabinoids Market Size by Application (2021-2027) (US$ Million)
Table 31. Europe Biosynthesis of Cannabinoids Market Share by Application (2021-2027)
Table 32. Japan Key Players Biosynthesis of Cannabinoids Revenue (2020-2021) (US$ Million)
Table 33. Japan Key Players Biosynthesis of Cannabinoids Market Share (2020-2021)
Table 34. Japan Biosynthesis of Cannabinoids Market Size by Type (2021-2027) (US$ Million)
Table 35. Japan Biosynthesis of Cannabinoids Market Share by Type (2021-2027)
Table 36. Japan Biosynthesis of Cannabinoids Market Size by Application (2021-2027) (US$ Million)
Table 37. Japan Biosynthesis of Cannabinoids Market Share by Application (2021-2027)
Table 38. Key Players in China
Table 39. Key Players in Southeast Asia
Table 40. Key Players in India
Table 41. Anandia Laboratories Company Details
Table 42. Anandia Laboratories Description and Business Overview
Table 43. Anandia Laboratories Biosynthesis of Cannabinoids Product
Table 44. Anandia Laboratories Revenue in Biosynthesis of Cannabinoids Business 2020 and 2021
Table 45. Anandia Laboratories Recent Development
Table 46. Gingko Bioworks Company Details
Table 47. Gingko Bioworks Description and Business Overview
Table 48. Gingko Bioworks Biosynthesis of Cannabinoids Product
Table 49. Gingko Bioworks Revenue in Biosynthesis of Cannabinoids Business 2020 and 2021
Table 50. Gingko Bioworks Recent Development
Table 51. Hyasynth Bio Company Details
Table 52. Hyasynth Bio Description and Business Overview
Table 53. Hyasynth Bio Biosynthesis of Cannabinoids Product
Table 54. Hyasynth Bio Revenue in Biosynthesis of Cannabinoids Business 2020 and 2021
Table 55. Hyasynth Bio Recent Development
Table 56. InMed Pharmaceuticals Company Details
Table 57. InMed Pharmaceuticals Description and Business Overview
Table 58. InMed Pharmaceuticals Biosynthesis of Cannabinoids Product
Table 59. InMed Pharmaceuticals Revenue in Biosynthesis of Cannabinoids Business 2020 and 2021
Table 60. InMed Pharmaceuticals Recent Development
Table 61. Librede Company Details
Table 62. Librede Description and Business Overview
Table 63. Librede Biosynthesis of Cannabinoids Product
Table 64. Librede Revenue in Biosynthesis of Cannabinoids Business 2020 and 2021
Table 65. Librede Recent Development
Table 66. Renew Biopharma Company Details
Table 67. Renew Biopharma Description and Business Overview
Table 68. Renew Biopharma Biosynthesis of Cannabinoids Product
Table 69. Renew Biopharma Revenue in Biosynthesis of Cannabinoids Business 2020 and 2021
Table 70. Renew Biopharma Recent Development
Table 71. Cronos Group Company Details
Table 72. Cronos Group Description and Business Overview
Table 73. Cronos Group Biosynthesis of Cannabinoids Product
Table 74. Cronos Group Revenue in Biosynthesis of Cannabinoids Business 2020 and 2021
Table 75. Cronos Group Recent Development
Table 76. Organigram Company Details
Table 77. Organigram Description and Business Overview
Table 78. Organigram Biosynthesis of Cannabinoids Product
Table 79. Organigram Revenue in Biosynthesis of Cannabinoids Business 2020 and 2021
Table 80. Organigram Recent Development
Table 81. Teewinot Life Sciences Company Details
Table 82. Teewinot Life Sciences Description and Business Overview
Table 83. Teewinot Life Sciences Biosynthesis of Cannabinoids Product
Table 84. Teewinot Life Sciences Revenue in Biosynthesis of Cannabinoids Business 2020 and 2021
Table 85. Teewinot Life Sciences Recent Development
Table 86. ICC International Cannabis Corp. Company Details
Table 87. ICC International Cannabis Corp. Description and Business Overview
Table 88. ICC International Cannabis Corp. Biosynthesis of Cannabinoids Product
Table 89. ICC International Cannabis Corp. Revenue in Biosynthesis of Cannabinoids Business 2020 and 2021
Table 90. ICC International Cannabis Corp. Recent Development
Table 91. Biotii Technologies Corp. Company Details
Table 92. Biotii Technologies Corp. Description and Business Overview
Table 93. Biotii Technologies Corp. Biosynthesis of Cannabinoids Product
Table 94. Biotii Technologies Corp. Revenue in Biosynthesis of Cannabinoids Business 2020 and 2021
Table 95. Biotii Technologies Corp. Recent Development
Table 96. Bristol-Myers Squibb Company Details
Table 97. Bristol-Myers Squibb Description and Business Overview
Table 98. Bristol-Myers Squibb Biosynthesis of Cannabinoids Product
Table 99. Bristol-Myers Squibb Revenue in Biosynthesis of Cannabinoids Business 2020 and 2021
Table 100. Bristol-Myers Squibb Recent Development
Table 101. Biogen Inc. Company Details
Table 102. Biogen Inc. Description and Business Overview
Table 103. Biogen Inc. Biosynthesis of Cannabinoids Product
Table 104. Biogen Inc. Revenue in Biosynthesis of Cannabinoids Business 2020 and 2021
Table 105. Biogen Inc. Recent Development
Table 106. GW Pharmaceuticals Company Details
Table 107. GW Pharmaceuticals Description and Business Overview
Table 108. GW Pharmaceuticals Biosynthesis of Cannabinoids Product
Table 109. GW Pharmaceuticals Revenue in Biosynthesis of Cannabinoids Business 2020 and 2021
Table 110. GW Pharmaceuticals Recent Development
Table 111. Biosynthesis of Cannabinoids Market Trends
Table 112. Biosynthesis of Cannabinoids Market Drivers
Table 113. Biosynthesis of Cannabinoids Market Challenges
Table 114. Biosynthesis of Cannabinoids Market Restraints
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Biosynthesis of Cannabinoids Market Share by Type in 2021 & 2027
Figure 2. THC Features
Figure 3. CBD Features
Figure 4. Others Features
Figure 5. Global Biosynthesis of Cannabinoids Market Share by Application in 2021 & 2027
Figure 6. Food Industry Case Studies
Figure 7. Medical Industry Case Studies
Figure 8. Others Case Studies
Figure 9. Biosynthesis of Cannabinoids Report Years Considered
Figure 10. Global Biosynthesis of Cannabinoids Market Size and Growth Rate (2020-2027) (US$ Million)
Figure 11. Global Biosynthesis of Cannabinoids Market Share by Regions (2020-2027)
Figure 12. Global Biosynthesis of Cannabinoids Market Share by Players in 2021
Figure 13. Global Biosynthesis of Cannabinoids Market Size Market Share by Type (2021-2027)
Figure 14. Global Biosynthesis of Cannabinoids Market Size Market Share by Application (2021-2027)
Figure 15. Global Biosynthesis of Cannabinoids Revenue Market Share by Application in 2021
Figure 16. North America Biosynthesis of Cannabinoids Market Size 2021-2027 (US$ Million)
Figure 17. Europe Biosynthesis of Cannabinoids Market Size 2021-2027 (US$ Million)
Figure 18. Japan Biosynthesis of Cannabinoids Market Size 2021-2027 (US$ Million)
Figure 19. Biosynthesis of Cannabinoids Market Size in China (2021-2027) (US$ Million)
Figure 20. Biosynthesis of Cannabinoids Market Size in Southeast Asia (2021-2027) (US$ Million)
Figure 21. Biosynthesis of Cannabinoids Market Size in India (2021-2027) (US$ Million)
Figure 22. Bottom-up and Top-down Approaches for This Report
Figure 23. Data Triangulation
Figure 24. Key Executives Interviewed